National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

hu14.18-interleukin-2 fusion protein

 An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.



Previous Definitions:HPV vaccine, HRT, HSIL, HSP, HTLV-1
Next Definitions:Hu3S193, HuAFP31, Huang Lian, huC242-DM4, HuHMFG1

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov